Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Previous revision
cl:3-mild-neurocog-disorder [on March 20, 2019]
 cl:3-mild-neurocog-disorder [on April 25, 2020]
Line 1: Line 1:
 ====== Mild Neurocognitive Disorder / Mild Cognitive Impairment (MCI) ====== ====== Mild Neurocognitive Disorder / Mild Cognitive Impairment (MCI) ======
 +{{INLINETOC}}
 ===== Primer ===== ===== Primer =====
 **Mild Neurocognitive Disorder** (also known as **Mild Cognitive Impairment**,​ or MCI) is a condition in which individuals demonstrate cognitive impairment with minimal impairment of instrumental activities of daily living (IADLs). Although it can be the first cognitive sign of [[geri:​dementia:​alzheimers|]],​ it can also be secondary to other disease processes (e.g. - neurologic, other neurodegenerative disorders, systemic, infectious, or psychiatric disorders). When there is //​significant//​ impairment to daily function, a [[cl:​2-major-neurocog-disorder|major neurocognitive disorder]] needs to be considered instead. **Mild Neurocognitive Disorder** (also known as **Mild Cognitive Impairment**,​ or MCI) is a condition in which individuals demonstrate cognitive impairment with minimal impairment of instrumental activities of daily living (IADLs). Although it can be the first cognitive sign of [[geri:​dementia:​alzheimers|]],​ it can also be secondary to other disease processes (e.g. - neurologic, other neurodegenerative disorders, systemic, infectious, or psychiatric disorders). When there is //​significant//​ impairment to daily function, a [[cl:​2-major-neurocog-disorder|major neurocognitive disorder]] needs to be considered instead.
 +
 ===== Diagnostic Criteria ===== ===== Diagnostic Criteria =====
 <WRAP group> <WRAP group>
 <WRAP half column> <WRAP half column>
 == Criterion A == == Criterion A ==
-Evidence of **//​modest//​** cognitive decline from a previous level of performance in one or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual motor, or social cognition) based on:+Evidence of **//​modest//​** cognitive decline from a previous level of performance in ''​1'' ​or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual motor, or social cognition) based on:
   - Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive function; and   - Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive function; and
   - A substantial impairment in cognitive performance,​ preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment.   - A substantial impairment in cognitive performance,​ preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment.
Line 40: Line 42:
 <panel icon="​fa fa-signal"​ size="​xs"​ title="​Behaviour Specifier">​ <panel icon="​fa fa-signal"​ size="​xs"​ title="​Behaviour Specifier">​
 **Specify:​** **Specify:​**
-  * **Without ​behavioral ​disturbance**:​ If the cognitive disturbance is not accompanied by any clinically significant behavioral disturbance.+  * **Without ​behavioural ​disturbance**:​ If the cognitive disturbance is not accompanied by any clinically significant behavioral disturbance.
   * **With behavioural disturbance** (//specify disturbance//​):​ If the cognitive disturbance is accompanied by a clinically significant behavioural disturbance (e.g., psychotic symptoms, mood disturbance,​ agitation, apathy, or other behavioural symptoms).   * **With behavioural disturbance** (//specify disturbance//​):​ If the cognitive disturbance is accompanied by a clinically significant behavioural disturbance (e.g., psychotic symptoms, mood disturbance,​ agitation, apathy, or other behavioural symptoms).
 </​panel>​ </​panel>​